$SNDX Syndax Pharmaceuticals Inc Insider Trading
Get free email notifications about insider trading in Syndax Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Syndax Pharmaceuticals Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in Syndax Pharmaceuticals Inc for free.
CIK Number: 0001395937
IRS Number: 320162505
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SNDX
Company Address: 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM 02451
Phone number: 781-419-1400
Market Capitalization: $163.37M
Prev close: $8.69
Average Daily Volume: 90,234
Days Low: $8.46
Year Low: $6.31
Year High: $18.03
Syndax Pharmaceuticals Inc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 28 2021 | SNDX | Syndax Pharmaceuti ... | Meyers Michael L. | SVP, Chief Medical ... | Buy | P | 15.46 | 500 | 7,730 | 15,666 | 15.2 K to 15.7 K (+3.30 %) |
Apr 22 2021 | SNDX | Syndax Pharmaceuti ... | Podlesak Dennis | Buy | P | 14.11 | 13,967 | 197,077 | 43,300 | 29.3 K to 43.3 K (+47.62 %) | |
Mar 03 2021 | SNDX | Syndax Pharmaceuti ... | Egros Fabrice | Option Exercise | M | 6.35 | 10,167 | 64,560 | 0 | ||
Mar 03 2021 | SNDX | Syndax Pharmaceuti ... | Egros Fabrice | Option Exercise | M | 7.20 | 74 | 533 | 0 | ||
Mar 03 2021 | SNDX | Syndax Pharmaceuti ... | Egros Fabrice | Sell | S | 24.31 | 74 | 1,799 | 16,000 | 16.1 K to 16 K (-0.46 %) | |
Mar 03 2021 | SNDX | Syndax Pharmaceuti ... | Egros Fabrice | Sell | S | 24.31 | 10,167 | 247,182 | 16,074 | 26.2 K to 16.1 K (-38.74 %) | |
Mar 03 2021 | SNDX | Syndax Pharmaceuti ... | Egros Fabrice | Buy | M | 7.20 | 74 | 533 | 26,241 | 26.2 K to 26.2 K (+0.28 %) | |
Mar 03 2021 | SNDX | Syndax Pharmaceuti ... | Egros Fabrice | Buy | M | 6.35 | 10,167 | 64,560 | 26,167 | 16 K to 26.2 K (+63.54 %) | |
Feb 10 2021 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Option Exercise | M | 7.20 | 35,156 | 253,123 | 0 | |
Feb 10 2021 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Sell | S | 20.55 | 35,156 | 722,403 | 48,336 | 83.5 K to 48.3 K (-42.11 %) |
Feb 10 2021 | SNDX | Syndax Pharmaceuti ... | Morrison Briggs | Chief Executive Off ... | Buy | M | 7.20 | 35,156 | 253,123 | 83,492 | 48.3 K to 83.5 K (+72.73 %) |
Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | A | 21.36 | 160,000 | 3,417,600 | 160,000 | |
Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Ordentlich Peter | Chief Scientific Of ... | Option Exercise | A | 21.36 | 80,000 | 1,708,800 | 80,000 | |
Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Karydas Daphne | Chief Financial Off ... | Option Exercise | A | 21.36 | 95,000 | 2,029,200 | 95,000 | |
Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Meury William | Grant | A | 0.00 | 16,000 | 0 | 16,000 | 0 to 16 K |